U.S. Immunoassay Market (2024 - 2030) Size, Share & Trends Analysis Report By Product (Reagent & Kits, Analyzers/Instruments), By Technology (RIA, ELISA), By Application, By Specimen, By End-use, By Region, And Segment Forecasts

Market Segmentation

U.S. Immunoassay Product Outlook (Revenue, USD Million, 2018 - 2030)
- Reagents & Kits
  - ELISA Reagents & Kits
  - Rapid Test Reagents & Kits
  - ELISPOT Reagents & Kits
  - Western Blot Reagents & Kits
  - Other Reagents & Kits
- Analyzers/Instruments
  - Open Ended Systems
  - Closed Ended Systems
- Software & Services
U.S. Immunoassay Technology Outlook (Revenue, USD Million, 2018 - 2030)
- Radioimmunoassay (RIA)
- Enzyme Immunoassays (EIA)
  - Chemiluminescence Immunoassays (CLIA)
  - Fluorescence Immunoassays (FIA)
- Rapid Test
- Others
U.S. Immunoassay Application Outlook (Revenue, USD Million, 2018 - 2030)
- Therapeutic Drug Monitoring
- Oncology
- Cardiology
- Endocrinology
- Infectious Disease Testing
- Autoimmune Diseases
- Others
U.S. Immunoassay End-use Outlook (Revenue, USD Million, 2018 - 2030)
- Hospitals
- Blood Banks
- Clinical Laboratories
- Pharmaceutical and Biotech Companies
- Academic Research Centers
- Others
U.S. Immunoassay Specimen Outlook (Revenue, USD Million, 2018 - 2030)
- Blood
- Saliva
- Urine
- Other Specimens
U.S. Immunoassay Regional Outlook (Revenue, USD Million, 2018 - 2030)
- West
- Midwest
- Northeast
- Southwest
- Southeast

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments